TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Tilray ( (TLRY) ) just unveiled an announcement.
On November 18, 2025, Tilray Brands, Inc. held its annual stockholders meeting where several key proposals were voted on. The re-election of John Herhalt as Class I director and the ratification of PricewaterhouseCoopers LLP as the independent accounting firm were approved. However, the proposal to amend the company’s governance structure to declassify the board and change director removal provisions did not pass, indicating mixed support for governance changes among stockholders.
The most recent analyst rating on (TLRY) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Tilray stock, see the TLRY Stock Forecast page.
Spark’s Take on TLRY Stock
According to Spark, TipRanks’ AI Analyst, TLRY is a Neutral.
Tilray’s overall stock score is primarily impacted by its poor financial performance, characterized by significant losses and liquidity issues. Technical analysis and valuation further highlight the stock’s challenges, with bearish momentum and a negative P/E ratio. The earnings call provided some positive developments, such as revenue growth and debt reduction, but these are overshadowed by ongoing operational challenges.
To see Spark’s full report on TLRY stock, click here.
More about Tilray
Tilray Brands, Inc. operates in the cannabis industry, offering a range of cannabis-related products and services. The company focuses on the development, production, and distribution of medical and recreational cannabis products.
Average Trading Volume: 72,279,852
Technical Sentiment Signal: Sell
Current Market Cap: $1.16B
Learn more about TLRY stock on TipRanks’ Stock Analysis page.